Brain metabolic alterations in Cushing's syndrome as monitored by proton magnetic resonance spectroscopy

NMR in Biomedicine

Volumn 12, Issue 6, 1999, Pages 357-363

  Khiat, Abdesslem ^a   Bard, Céline ^b   Lacroix, André ^b   Rousseau, Julie ^b   Boulanger, Yvan ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Brain metabolites; Choline; Cushing's syndrome; Glucocorticoids; Hypercortisolism; Magnetic resonance spectroscopy

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID;

ADRENAL DISEASE; ADRENAL HYPERPLASIA; ADULT; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CUSHING SYNDROME; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCORTISOLISM; NUCLEAR MAGNETIC RESONANCE; OBESITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL ANALYSIS;

ADULT; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; CUSHING SYNDROME; FEMALE; HUMANS; HYDROCORTISONE; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PHOSPHOCREATINE; PROTONS; RECEPTORS, GLUCOCORTICOID;

EID: 0032849567     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199910)12:6<357::AID-NBM584>3.0.CO;2-U     Document Type: Article

References (56)

1. Nieman, L. and Cutler, Jr, G. B. Cushing's syndrome. In Endocrinology, L. J. De Groot, ed., pp. 1741-1770, Saunders, Philadelphia, PA (1995).
2. Tizabi, Y., Aguilera, G. and Gilad, G. M. Age-related reduction in pituitary corticotropin-releasing hormone receptors in two rat strains. Neurobiol. Aging 13, 227-230 (1992).
3. Sapolsky, R. and Pulsinelli, W. Glucocorticoids potentiate ischemic injury to neurons. Therapeutic implications. Science 229, 1397-1403 (1985).
4. Starkman, M. N., Gebarski, S. S., Berent, S. and Schteingart, D. E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol. Psychiat. 32, 756-765 (1992).
5. Noël, B., Bard, C., Leclerc, I., Cordeau, M.-P., Bélair, L. and Lacroix, A. Atrophie cérébrale dans la maladie de Cushing. Congrès des sciences neurologiques, Montreal (1995).
6. Momose, K. J., Kjellberg, R. N. and Kliman, B. High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease. Neuroradiology 99, 341-348 (1971).
7. Forget, H., Cohen, H., Somma, M. and Lacroix A. Glucocorticoid effects in Cushing's syndrome approximate cognitive aging. Brain Cogn. 2, 267 (1996).
8. Schteingart, D. E. Cushing's syndrome. Endocrinol. Metab. Clin. North Am. 18, 311-338 (1989).
9. Mauri, M., Sinforiani, E., Bono, G., Vignati, F., Berselli, M. E., Attanasio, R. and Nappi, G. Memory impairment in Cushing's disease. Acta Neurol. Scand. 87, 52-55 (1993).
10. Lee, J. H., Arcinue, E. and Ross B. D. Brief report: organic osmolytes in the brain of an infant with hypernatremia. New Engl. J.Med. 331, 439-442 (1994).
11. Arnold, D. L. and De Stefano, N. Magnetic resonance spectroscopy in vivo: applications in neurological disorders. Ital. J. Neurol. Sci. 18, 321-329 (1997).
12. 1H chemical shift selective (CHESS) imaging. Phys. Med. Biol. 30, 341-344 (1985).
13. Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hanicke, W. and Sauter, R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn. Reson. Med. 9, 79-93 (1989).
14. de Beer, R. and van Ormondt, D. Analysis of NMR data using time domain fitting procedure. In NMR Basic Principles and Progress, P. Diehl, E. Fluck, H. Gunther, R. Kosfeld, J. Seelig and M. Rudin, eds., vol. 26, pp. 201-248. Springer, Berlin (1992).
15. Pijnappel, W. W. F., van den Boogaart, A., de Beer, R. and van Ormondt, D. SVD-based quantification of magnetic resonance signals. J. Magn. Reson. 97, 122-134 (1992).
16. Petroff, O. A. C., Ogino, T. and Alger, J. R. High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes. J. Neurochem. 51, 163-171 (1988).
17. Klunk, W. E., Xu, C. J., Panchalingham, K., McClure, R. J. and Pettegrew, J. W. Analysis of magnetic resonance spectra by mole percent: comparison to absolute units. Neurobiol. Aging 15, 133-140 (1994).
18. Kreis, R., Ernst, T. and Ross, B. D. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J. Magn. Reson. Ser. B 102, 9-19 (1993).
19. De Kloet, E. R., Vreugdenhil, E., Oitzl, M. S. and Joëls, M. Brain corticosteroid receptor balance in health and disease. Endocrine Rev. 19, 269-301 (1998).
20. McEwen, B. S., Weiss, J. and Schwartz, L. Selective retention of corticosterone by limbic structures in rat brain. Nature 220, 911-912 (1968).
21. McEwen, B. S. Glucocorticoid receptors in the brain. Hosp. Pract. (Off. Ed.) 15, 107-121 (1988).
22. van Eekelen, J. A. M., Jiang, W., DeKloet, E. R. and Bohn, M. C. Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J. Neurosci. Res. 21, 88-94 (1988).
23. Sapolsky, R. M. The adrenal axis. In Handbook of the Biology of Aging, E. L. Schneider and J. W. Rowe, eds, Third edition, pp. 330-346. Academic Press, New York (1990).
24. +)-stimulated ATPase activity and on bilayer fluidity of dog brain synaptosomal plasma membranes. Neurochem. Res. 10, 1605-1613 (1985).
25. Golden, G. A., Rubin, R. T. and Mason, R. P. Steroid hormones partition to distinct sites in a model membrane bilayer: direct demonstration by small-angle X-ray diffraction. Biochim. Biophys. Acta 1368, 161-166 (1998).
26. Ross, B., Kreis, R. and Ernst, T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur. J. Radiol. 14, 128-140 (1992).
27. Hashimoto, T., Tayama, M., Miyazaki, M., Fujii, E., Harada, M., Miyoshi, H., Tanouchi, M. and Kuroda, Y. Developmental changes in proton MR spectroscopy of the brain. No To Hattatsu 26, 26-31 (1994).
28. Hashimoto, T., Tayama, M., Miyazaki, M., Fujii, E., Harada, M., Miyoshi, H., Tanouchi, M. and Kuroda, Y. Developmental changes investigated with proton MR spectroscopy. Dev. Med. Child Neurol. 37, 398-405 (1995).
29. Charles, H. C., Lazeyras, F., Krishnan, K. R. R., Boyko, O. B., Patterson, L. J. and Doraiswamy, P. M. Proton spectroscopy of human brain: effects of age and sex. Prog Neuropsychopharmac. Biol. Psychiat. 18, 995-1004 (1994).
30. Renshaw, P. F., Lafer, B., Babb, S. M., Fava, M., Stoll, A. L., Cristensen, J. D., Moore, C. M., Yurgelun-Todd, D. A., Bonello, C. M., Pillay, S. S., Rothchild, A. J., Nierenberg, A. A., Rosenbaum, J. F. and Cohen, B. M. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiat. 41, 837-843 (1997).
31. Cohen, B. M., Renshaw, P. F., Stoll, A. L., Wurtman, R. J., Yurgelun-Todd, D. and Babb, S. M. Decreased brain choline uptake in older adults: an in vivo proton magnetic resonance spectroscopy study. JAMA 274, 902-907 (1995).
32. Kuhmonen, J., Sivenius, J., Riekkinen, Sr, P. J. and Kauppinen, R. A. Decrease in brain-containing compounds following a short period of global ischemia in gerbils as detected by H NMR spectroscopy in vivo. NMR Biomed. 7, 231-236 (1994).
33. Fulham, M. J., Bizzi, A., Dietz, M. J., Shih, H. H., Raman, R., Sobering, G. S., Frank, J. A., Dwyer, A. J., Alger, J. R. and Di Chiro, G. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185, 675-686 (1992).
34. 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci. 58, 1929-1935 (1996).
35. Ross, B. D., Danielsen, E. R. and Blüml, S. Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig. Dis. 14 (suppl. 1), 30-39 (1996).
36. 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia. Acad. Radiol. 1, 211-216 (1994).
37. Wolkowitz, O. M., Reus, V. I., Weingartner, H., Thompson, K., Breier, A., Doran, A., Rubinow, D. and Pickar, D. Cognitive effects of corticosteroids. Am. J. Psychiat. 147, 1297-1303 (1990).
38. Ismail, K. and Wessely, S. Psychiatric complications of corticosteroid therapy. Br. J. Hosp. Med. 53, 495-499 (1995).
39. Takahashi, A., Ishimaru, H., Ikarashi, Y., Kishi, E. and Maruyama, Y. Hypothalamic cholinergic activity and 2-deoxyglucose-induced hyperglycemia. Brain Res. Bull. 43, 65-68 (1997).
40. Bertoni-Freddari, C., Mervis, R. F., Giuli, C. and Pieri, C. Chronic dietary choline modulates synaptic plasticity in the cerebellar glomeruli of aging mice. Mech. Ageing Dev. 30, 1-9 (1985).
41. Charles, H. C., Lazeyras, F., Krishnan, K. R. R., Boyko, O. B., Payne, M. and Moore, D. Brain choline in depression: in vivo detection of potential phannacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog. Neuropsychopharmac. Biol. Psychiat. 18, 1121-1127 (1994).
42. Francis, P. T., Palmer, A. M. and Sims, N. R. Neurochemical studies of early-onset Alzheimer's disease. New Engl. J. Med. 313, 7-11 (1985).
43. Strong, R., Rehwaldt, W. and Wood W. G. Intra-regional variations in the effect of aging on high affinity choline uptake, choline acetyltransferase and muscarinic cholinergic receptors in rat neostriatum. Exp. Gerontol. 21, 177-186 (1986).
44. Mervis, R., Horrocks, L., Demeniuk, P., Wallace, L., Meyer, D. R., Beall, S. and Naber, E. Neurobehavioral effects of chronic choline-containing diets on the adult and aging C57BL/6NNIA mouse brain. Ann. NY Acad. Sci. 444, 469-470 (1985).
45. 12 improved the memory impairment following lesioning of nucleus basalis in rats. Life Sci. 62, 813-822 (1998).
46. Alvarez, X. A., Laredo, M., Corso, D., Fernandez-Novoa, L., Mouzo, R., Perea, J. E., Daniele, D. and Cacabelos, R. Citicoline improves memory performance in elderly subjects. Meth. Find. Exp. Clin. Pharmac. 19, 201-210 (1997).
47. Stoll, A. L., Sachs, G. S., Cohen, B. M., Lafer, B., Christensen, J. D. and Renshaw, P. F. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium treated patients. Biol. Psychiat. 40, 382-388 (1996).
48. Meyerhoff, D. J., Mackay, S., Constant, J. M., Normand, D., van Dyke, G., Fein, G. and Weiner, M. W. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann. Neurol. 36, 10-47 (1994).
49. Schuff, N., Amend, D. L., Meyerhoff, D. J., Tanabe, J. L., Normand, D., Fein, G. and Weiner, M. W. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 207, 91-102 (1998).
50. Arnold, D. L., Shoubridge, E. A., Villemure, J. G. and Feindel W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo: preliminary observations. NMR Biomed. 3, 184-189 (1990).
51. Cendes, F., Anderman, F., Preul, M. C. and Arnold, D. L. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann. Neurol. 35, 211-216 (1994).
52. Gillard, J. H., Barker, P. B., van Zijl, P. C. M., Bryan, R. N. and Oppenheimer, S. M. MR spectroscopy in acute middle cerebral artery stroke. AJNR Am. J. Neuroradiol. 17, 873-886 (1996).
53. 1H NMR spectroscopy: N-acetyl-aspartate, creatine and choline. NMR Biomed. 4, 47-52 (1991).
54. Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W. and Chrousos, G. P. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 82, 912-919 (1997).
55. Heinz, E. R., Martinez, J. and Haengeli, A. Reversibility of cerebral atrophy in anorexia nervosa and Cushing's syndrome. J. Comput. Assist. Tomogr. 1, 415-418 (1977).
56. Bentson, J., Reza, M., Winter, J. and Wilson, G. Steroids and apparent cerebral atrophy on computed tomography scans. J. Comput. Assist. Tomogr. 2, 16-23 (1978).